Shake-up at AstraZeneca as two immuno-oncology leaders leave
January 05, 2015 at 12:01 PM EST
* Immune-boosting cancer drugs critical to company's future
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.